Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,483
+$251 QoQ
Shares Held
5
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,701
of 1,735 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026S&T Bank/PA holds $4,851,787 across 8 Biotechnology names. VRTX ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
55,553 | $4,830,333 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $4,988 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
18 | $4,337 | |
| 4 | INSM |
INSMED Inc
|
37 | $3,944 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12 | $3,612 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5 | $2,483 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
32 | $1,831 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
100 | $259 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,483 | 5 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,232 | 5 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,813 | 4 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,566 | 4 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,335 | 3 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $1,454 | 3 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||